energi-f703
Small moleculeexperimental
Clinical trial activity
3 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
3
Phase 3
1
Phase 4
0
Earliest trial started Jun 1, 2016 (NCT02672436)
Timeline
Indications
Mechanism of action
PRKAB1 activator
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- energi-f703
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05930210 | Phase 3 | May 30, 2023 | Energenesis Biomedical Co., Ltd. |
| NCT04078555 | Phase 2 | Dec 1, 2019 | Energenesis Biomedical Co., Ltd. |
| NCT02672436 | Phase 2 | Jun 1, 2016 | A2 Healthcare Taiwan Corporation, Energenesis Biomedical Co., Ltd. |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Energenesis Biomedical Co., Ltd. | For profit | 3 | 3 | 2 | 2016 |
| A2 Healthcare Taiwan Corporation | For profit | 1 | 0 | 1 | 2016 |
2 organizations
Page 1 / 1